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Objective: To determine the frequency of different alleles of the vacA gene among the strains of Helicobacter pylori 
isolated from children and adults, and to compare vacuolating cytotoxin production with different combinations of vacA 
alleles. 
Methods: H. pyloristrains were isolated from the gastric biopsy samples of 100 patients with duodenal ulcer (32) and 
chronic gastritis (68). Bacterial DNA was extracted and the vacA alleles typed using PCR. Cytotoxin activity was assessed 
by an Intestine 407 cell vacuolation assay. 
Results: Alleles s l  and s2 of vacA were identified in 72% and 28% of the tested strains, respectively. Of the 72 type s l  
strains, 71 were classified as type s la  and only one as slb. The predominant sequence observed in the vacA middle 
region was the m2 type (65%). Combinations of vacA genotypes sla ml, s la m2 and s2 m2 were found in 35%, 36% 
and 28% of strains, respectively. Vacuolating cytotoxin was produced by vacA s la  m l  strains isolated from patients with 
duodenal ulcer (84.6%) and chronic gastritis (68.2%). Subtype s la  m2 strains expressed vacuolating cytotoxin less 
frequently in both duodenal ulcer (47.1%) and chronic gastritis (21.1%) patients (p<O.OI). Antibodies to VacA (89 kDa) 
were found in 71.9% of patients with duodenal ulcer and in 42.6% of patients with chronic gastritis. 
Conclusions: Most H. pylori vacA sl rnl strains are toxic, whereas s2 m2 forms are essentially non-toxic. 
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Helicobacter pylori infects the gastric antrum of half the 
world's population, and represents the major cause of 
acute and chronic gastroduodenal pathologies [ 11. 
An important virulence determinant of H. pylovi is 
the vacuolating cytotoxin (VacA) which induces the 
formation of intracellular vacuoles in eukaryotic cells in 
vitro. So far, the vacA gene has been identified in nearly 
all analyzed strains [2]. However, only about 40-50% 
of H. pylori strains can produce detectable amounts of 
this cytotoxin [3,4]. Recently, Atherton et a1 [5] 
demonstrated mosaic organization of the VUCA genes; 
three different families ofvacA signal sequence (sla, slb 
and s2) and two different families of middle-region 
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alleles (ml and m2) have been identified so far. The 
detection of cytotoxic activity in the vacuolating assay 
depends on the cell line used in the experiment. 
Pagliaccia et al [6] suggested that H. pylori cytotoxin has 
different receptor binding sites associated with ml and 
m2 middle regions. 
Another virulence factor produced by H .  pylori is 
protein CagA. In contrast to the t a d  gene, the cugA 
gene is present in only 50-60% of the H. pylori strains 
[7]. The c u g l  gene is part of a larger genomic entity, 
which contains multiple genes that are related to the 
virulence and pathogenicity of H. pylori [8]. The CagA 
protein was partly responsible for the antiproliferative 
activity of somatic fractions of H. pylori strains, and 
CagA might be one, but not the only, bacterial 
inhibitor of T-cell function [9]. Moreover, infection 
with CagA-positive strains appears to be associated 
with increased risk of gastric atrophy and gastric cancer 
of the intestinal type [lo]. 
The aim of this work was to determine the fre- 
quency of different alleles of the vacA gene among the 
strains of H. pylori isolated from children and adults. 
Thus, we also examined the vacuolating activity and the 
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genotypes of the zwA gene reported to be associated 
with the ability to secrete vacuolating cytotoxin. 
MATERIALS AND METHODS 
Bacterial strains 
H. pylovi strains were isolated from the gastric biopsy 
samples of 100 consecutive, ethnically homogeneous 
patients (59 children and 41 adults; age range 9-82 
years) who underwent endoscopy in the Departments 
of Gastroenterology for children and adults, University 
of Medicine, Wroclaw, Poland, between 1996 and 
1997. None of the patients had received antibiotics, or 
antisecretory or non-steroidal anti-inflammatory drugs. 
The endoscopic and histopathologic findings were 
duodenal ulcer 32, and chronic gastritis 68. After the 
primary isolation and identification of the gastric 
organisms as H. pylori, the strains were frozen at - 70°C 
in Brucella broth containing 15% glycerol until their 
use in these studies. Subsequently, the bacteria were 
cultured on Columbia agar medium with horse blood 
(7%) for 3 days at 37°C under micro-aerobic conditions 
(5% 0 2 ,  15% CO2, 80‘% Nz). 
DNA isolation from bacterial strains 
Colonies of H .  pylori from one plate were scraped 
and transferred into 200 pL of ice-cold STE buffer 
(150 m M  NaC1, 10 mM Tris HC1, 1 M EDTA) con- 
taining lysozyme (100 mg/L). Chromosomal DNA was 
extracted by the protease and phenol-chloroform 
method [ 111. 
PCR 
P C R  amplification was performed in 50-pL reaction 
mixtures containing approximately 100 ng genomic 
DNA, 1 pM primers, all four deoxynucleotide triphos- 
phates at 0.2 mM each, 50 mM KC1, 10 mM Tris-HC1 
(pH 8.3), 1.5 mM MgCl2, 0.01% gelatin and 3.5 U of 
Taq polymerase (Boehringer Mannheim, Mannheim, 
Germany). The reaction included an initial denatura- 
tion of target DNA at 94°C for 5 min, and then 30 
cycles at 94°C for 30 s, 50°C for 30 s, and 72°C for 
30 s. The final cycle used 5 min a t  72°C to ensure full 
extension of the product. The P C R  reactions were 
performed in Uno-Thermoblock apparatus (Bionietra, 
Gethingen, Germany). O n  the basis of published 
sequences [S], primers were synthesized to amplifj the 
tucA signal and middle regions. 
Cytotoxin assay for cell vacuolation 
All strains used in this study were investigated for the 
production of vacuolating cytotoxin activity. As a 
control, three reference strains of H. pylori were used. 
Two of these (NCTC 11634 and ACTC 49503) 
produced cytotoxin (Tax+), and the other one (Tx30A) 
did not (Tox-). 
The H .  pylori strains for the cytotoxin production 
assay were cultured in Brucella broth (Difco, Detroit, 
MI, USA) supplemented with 5% fetal calf serum and 
1% vitox (Oxoid, Basingstoke, UK) for 48 h on a rotary 
shaker at  37°C under micro-aerophilic conditions (10% 
CO?, 5% 0 2  and 85% Nz). Bacterial suspensions were 
centrifuged (1500 rev/min) at 4°C for 15 min, the 
supernatant was passed through a 0.2-pm-pore filter 
(Sartorius, Gottingen, Germany), and cell-free super- 
natants were stored at -70°C. 
Intestine 407 cells (human embryonic intestine 
cells) were grown in Optimem medium (Gibco) supple- 
mented with 6% fetal calf serum, 2 mM glutamine, 
gentamicin 50 mg/L, and anti-PPLO reagent 60 mg/L 
(Gibco, Paisley, UK). Ninety-six-well culture plates were 
seeded with a suspension of 0.1 mL of freshly trypsin- 
ized cells at a final concentration of 5 X lo3 cells/well, 
and incubated at 37°C in a 5% CO, atmosphere for 
Cell-free culture broth supernatants were diluted 
1:2 to 1:356, and 0.1 mL of each dilution was added to 
samples of tissue-culture medium. These were incu- 
bated at 37°C in an atmosphere containing 5% COz for 
24 h. Intracellular vacuolation in >50% ofthe Intestine 
407 cells in a well indicated the presence of the 
cytotoxin. 
18-14 h. 
lmmunoblot assay 
Serum samples were stored at -70°C until serologic 
testing was performed. IgG antibodies to VacA antigen 
of H. pylori were determined by immunoblot assay 
(Helico Blot 2.0 Genelabs Diagnostics, Singapore). 
The test devices were run according to the manu- 
facturers’ directions. The HelicoBlot 2.0 membrane 
strips were incubated in wash buffer, after which a 
1 : l O O  dilution of sera in blocking buffer was added 
to each strip. Following a 1-h incubation at  room 
temperature, the sera were aspirated and the strips were 
washed three times. After washing, alkaline phosphatase 
goat antihuman IgG conjugate diluted 3 : 1000 in 
blocking buffer was added to each strip, and the strips 
were incubated for 1 h at room temperature. After 
washing again, substrate solution was added to each 
strip, and the strips were incubated for 15 min on the 
rocking platform. The strips were removed and dried 
before mounting on non-absorbent paper. Serum- 
positive and -negative controls were incubated with 
each batch of strips. 
Statistical methods 
Proportions were compared using the x2 test with 
Yates’s correction. 
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RESULTS 
Distribution of vacA alleles in H. pyloristrains 
One hundred strains of H. pylori isolated from gastric 
biopsy samples were investigated for the diversity of the 
vucA gene. Typing of the vucA alleles was performed by 
PCR as described previously [5]. Five sets of primers 
[5] were used to specifically ampli@ the signal (sla, slb, 
s2) and middle (ml,  m2) (Figure 1) regions of the 
analyzed VUCA genes. Of the 72 type s l  strains, 71 were 
classified as type s l a  and only one as slb (Table 1). 
Allele s2 was identified in 28% of H. pylori strains. 
In strains from children with duodenal ulcer, allele 
s l a  occurred with a higher frequency (100%) than 
in strains from the chronic gastritis group (44.2%) 
(x2=12.83, p<O.OOl). In adult patients, there was no 
difference in the frequency of s l a  allele occurrence 
between duodenal ulcer (87.5%) and chronic gastritis 
(88%). 
The predominant sequence observed in the VUCA 
middle region was the m2 type, identified in 65% of all 
H. pylori strains. Allele m2 was more frequent in 
children with chronic gastritis (74.4%) and adults with 
duodenal ulcer (68.8%) (p<O.OOl). 
Combinations of s l a  ml ,  s l a  m2 and s2 m2 were 
found in 35%, 36% and 28% of the tested strains, 
respectively. Fifty per cent of strains of s l a  m l  type and 
50% of strains of s la  m2 type were observed in children 
with duodenal ulcer, whereas genotype s2 m2 was 
not detected. In contrast, 53.5% of the children with 
chronic gastritis were infected with strains of the VUCA 
sequence s2 m2. The combination sla m2 was domi- 
nant in adults with duodenal ulcer (56.25%). Adults 
with chronic gastritis showed similar proportions of s l a  
m l  (44%) and s l a  m2 (44%) vucA genotypes. 
Vacuolating activity and typing of the vacA gene 
Ofthe 100 H. pylori strains tested, 41 (41%) were found 
to express vacuolating cytotoxic activity (Table 2): 
74.3% of s l a  m l  type strains, but only three of 28 
(10.7%) H. pylori strains with s2 m2 produced vacuo- 
lating cytotoxin (x2=22.81, p<O.OOOl). There was also 
strain designation 
m2 - 352 bp * m l  - 290bp 
Figure 1 An example of v a d  middle-region typing. The middle region of tucA was amplified by PCR using pairs of 
primers. VA3-F and VA3-R or VA4-F and VA4-R, designated for identification of m l  or m2 allelic types respectively [5]. 
M, molecular weight marker VIII. 
Table 1 Distribution of v a d  alleles in patient groups 
Children Adults 
n=59 n=41 
Duodenal ulcer Chronic gastritis Duodenal ulcer Chronic gastritis Total 
vacA type n=16 (“h) n=43 (%) n=16 (“A) n = 2 5  (“A) n=100 
s la  
slb 
S 2  
ml 
m2 
sfa ml 
s la  m2 
slb m2 
s2 m2 
16 (100) 
- 
19 (44.2)a 
1 (2.3) 
23 (53.5) 
11 (25.6) 
32 (74.4) 
11 (25.6) 
8 (18.6) 
1 (2.3) 
23 (53.5) 
14 (87.5) 
- 
2 (12.5) 
5 (31.25) 
11 (68.75) 
5 (31.25) 
9 (56.25) 
- 
2 (12.5) 
22 (88) 
- 
3 (12) 
11 (44) 
11 (44) 
11 (44) 
3 (12) 
14 (56) 
- 
71 (71) 
28 (28) 
1 (1) 
35 (35) 
35 (35) 
1 (1) 
65 (65) 
36 (36) 
28 (28) 
H. pylori strains from chldren with chronic gastritis, d e l e  sla occurred less frequently than in the other groups (x2=12.83, p<0.001) 
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Table 2 Vacuolating cytotoxin production and different combinations of MCA alleles 
Vacuolating activity 
- N vacl4 type Number of strains + 
l a  sla nil 35 26 (74.3%) 9 (25.7%) 
2 s l a  in2 36 12 (33.3%) 24 (66.7%) 
3 s lb  m2 1 0 1 
4 s2 m2 28 3 (10.7%) 25 (89.3%) 
Total 100 41 (41.0%) 59 (59.0'Y") 
"Using x2 test with Yates's correction, we compared: 1 and 2,  x2=11.96, p=0.0005; 1 and 4, x2=22.81, p=O.0001; 2 and 4, ~ ' ~ 4 . 4 9 ,  
p=O.O341. 
p<o.o1 pio.1 p o . 0 1  
0 Chronic gastritis 
$ 
Children Adults Total 
Figure 2 Frequency of vacuolating cytotoxin production by strains of H .  pylori isolated from children and adults. 
Table 3 Distribution of v a ~ 4  alleles, frequency of vacuolating cytotoxin production and VacA antibodies 
Duodenal ulcer Chronic gastritis 
n=32 (Oh) n=68 (%) 
Vacuolating cytotoxina Anti-VacA antibodiesb Vacuolating cytotoxina Anti-VacA antibodiesh 
- + - + - + - vacA type + 
~~~ 
Sla m l  11 (84.6) 2 (15.4) 12 (92.3) 1 (7.7) 15 (68.2) 7 (31.8) 18 (81.8) 4 (18.2) 
Sla mZ 8 (47.1) 9 (52.9) 10 (58.8) 7 (41.2) 4 (21.1) 15 (78.9) 6 (31.6) 13 (68.4) 
1 1 Slb m? - - 
s2 ml 1 1 1 1 2 (7.7) 24 (92.3) 4 (15.4) 22 (84.6) 
Total 20 (62.5) 1 1  (37.5) 23 (71.9) 9 (28.1) 21 (30.9) 47 (69.1) 29 (42.6) 39 (57.3) 
'There were significant differences in the production of cytotoxin between s l a  ml strains and sla m2 strains in both duodenal ulcer 
(x2=3.0, p=0.0831) (x2 test with Yates's correction) and chronic gastritis (x2=7.31, p=0.0069) (x2 test with Yates's correction) patients. 
bAntibodies against t a d  in serum samples were detected more frequently in H. pylori sla ml-infected than in H. pylori sla m2-infected 
patients, irrespective of whether they suffered from duodenal ulcer (x2= 10.84, p=O.001) (x' test with Yates's correction) or chronic gastritis 
(x2=8.63, p=0.0033) (x' test with Yates's correction). 
- - - - 
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a significant difference in vacuolating activity between 
s l a  ml and s l a  m2 (~'=11.96, p=O.OOOS) as well as 
between s l a  ma and s2 m2 (~"4.49, p=0.0341). 
Cytotoxin-positive H. pylori strains were found 
more frequently (x2=6.93, p=0.0085, pcO.01) in 
duodenal ulcer (62.5%) than in chronic gastritis (25%) 
child patients (Figure 2). A similar pattern was detected 
in adult patients. The strains isolated from those with 
duodenal ulcer produced vacuolating cytotoxin more 
frequently (62.5%) than the strains from chronic 
gastritis patients (36%), and this difference was statis- 
tically significant (x2=2.76, p0.0969) .  
Vacuolating cytotoxin was produced by imA s l a  
ml  strains isolated from patients with duodenal ulcer 
(84.6%) and chronic gastritis (68.2%) (Table 3). Subtype 
s l  a m2 strains expressed vacuolating cytotoxin less 
frequently in both duodenal ulcer (47.1%) and chronic 
gastritis (21.1%) patients. The difference between sub- 
types sla m l  and s l a  m2 was statistically significant 
(duodenal ulcer x2=3.0, p=0.0831, chronic gastritis 
~ '=7.31,  p=0.0069). Only three of 28 investigated s2 
m2 strains showed vacuolating activity in vitro. 
Anti-VacA antibodies 
Antibodies to Vac (89 kDa) were found in 71.9% of 
patients with duodenal ulcer and in 42.6% of patients 
with chronic gastritis (Table 3 ) .  Antibodies against 
vacuolating cytotoxin were detected in 92.3% of serum 
samples from patients with duodenal ulcer infected 
with s l a  m l  strains and in 58.8% ofserum samples from 
patients infected with s l a  m2 (x2=10.84, p<O.OI). 
In patients with chronic gastritis infected with type 
s l a  m l  and s l a  m2 H .  pylon' strains, antibodies to 
vacuolating cytotoxin were observed in 81.8% and 
31.6%, respectively. This difference was statistically 
significant (x2=8.63, p=0.0033). Only 15.4% ofpatients 
infected with type s2 m2 had antibodies against VacA. 
DISCUSSION 
In our study, the vucA allele s l a  of H .  pylovi was found 
to be strongly associated with duodenal ulcer. On the 
other hand, the vucA allele s2 was detected pre- 
dominantly @<0.001) in isolates from children with 
chronic gastritis (74.4%) and was rarely identified in 
strains isolated from ulcer patients (50%). A similar 
finding was reported by Strobe1 et al [12], who isolated 
H. pylori genotype s l  from as many as 96%. and H. 
pylori genotype s2 from only 4%, of patients with 
duodenal ulcerations. 
As may be inferred from the reports of other 
investigators, the signal sequences of the vucA genotype 
vary from one part of the world to another [13-151, 
Thus, subtype sla is predominant in northern Europe 
and Australia, whereas subtype slb is prevalent in South 
America [13]. The majority of the Portuguese strains 
(72%) contained the slb allele, whereas most of the 
Dutch strains (61%) contained type s l a  [14]. This 
highly significant difference is observed in both non- 
ulcer dyspepsia and ulcer patients. In our study, we 
detected the s l a  allele in 71% of H. pylori strains and in 
only one (of 100) H. pylori strains containing slb type 
allele. 
Furthermore, some of the investigators suggested 
that infection with cytotoxin-positive strains was 
correlated with the development of gastroduodenal 
diseases. Figura et al [3] reported that 67% of the H. 
pylori strains isolated from patients with peptic ulcers, 
and only 30% of strains from patients with chronic 
gastritis, produced cytotoxin. The results of our 
study show that vacuolating cytotoxin activity was 
expressed in 62.5% of the H. pyylori strains isolated from 
patients with duodenal ulcer and in 29.4% of the 
H.  pylori isolates from patients with chronic gastritis. 
This difference was statistically significant (~'=8.63, 
p=0.0033). 
As reported by Atherton et a1 [16] and Cover et al 
[I71 cytotoxic activity was higher in s l a  m l  than in s l a  
m2 strains and seemed to be either completely absent 
or very rare in s2 m2 strains. The vucA genotype s l a  
was found to be strongly associated with the presence 
of the pathogenicity marker cugA [16,18], whereas the 
strains with the vucA genotype s2 mostly lacked the 
cugA gene. 
Our study revealed that the vucA s l a  m l  strains 
produced higher levels of vacuolating cytotoxin activity 
than sla m2 strains. Thus, in patients with duodenal 
ulcer, 84.6% of the vacA s la  m l  strains and 47.7% of 
the vucA s l a  m2 strains produced vacuolating cytotoxin 
(p=O.O831). A sinilar pattern was observed in patients 
with chronic gastritis: 68.2% of s l a  m l  and 21.1% of 
s l a  m2 produced vacuolating cytotoxin (p=0.0069). 
As far as the vucA s2 m2 type is concerned, vacuolating 
cytotoxin was produced by only three of the 28 
investigated strains. 
For each type of allele, we found that the frequency 
of VacA antibody occurrence was slightly higher than 
that of the cytotoxic activity in the broth filtrates of the 
H. pylori strains isolated from the same patients. For 
example, 62.5% of the H. pylori strains examined from 
patients with duodenal ulcer showed vacuolating activity, 
and 71.9% of the serum samples had anti-VacA anti- 
bodies, but this difference was statistically insignificant 
(~"0.64, p=0.4245). The difference between vacuo- 
lating activity and expression of VacA protein suggests 
that some strains secreted either inactive cytotoxin or 
only a small amount of active cytotoxin. As a result, we 
detected the presence of antibodies against cytotoxin by 
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immunoblot analysis, but we failed to detect cytotoxin 
by the vacuolating assay. 
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